CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Mainly Beta (13760)
(-)
Architecture: Sandwich (5577)
(-)
Topology: Immunoglobulin-like (3897)
(-)
Homologous Superfamily: Immunoglobulins (2282)
(-)
Mouse (Mus musculus) (152)
1GL4B:1769-1857NIDOGEN-1 G2/PERLECAN IG3 COMPLEX
1H3PL:109-211; H:114-213; L:1-108; H:1-113STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
1H5BB:1-111; D:1-111; A:1-113; C:1-113T CELL RECEPTOR VALPHA11 (AV11S5) DOMAIN
1HK6A:3-97RAL BINDING DOMAIN FROM SEC5
1OB1A:108-210; D:108-210; A:1-107; D:1-107; B:114-212; E:114-212; B:1-113; E:1-113CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
1OD7A:1-119N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-(NAPHTHYL-2-CARBONYL)-AMINO-9-DEOXY-NEU5AC (NAP COMPOUND)
1OD9A:1-119N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-BENZOYL-AMINO-9-DEOXY-NEU5AC (BENZ COMPOUND)
1ODAA:1-119N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-(BIPHENYL-4-CARBONYL)-AMINO-9-DEOXY-NEU5AC (BIP COMPOUND)
1QKZL:109-211; H:114-212; L:1-108; H:1-113FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G
1QLFB:1-99; A:182-272MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G
1QNZH:113-231; L:1-112NMR STRUCTURE OF THE 0.5B ANTI-HIV ANTIBODY COMPLEX WITH THE GP120 V3 PEPTIDE
1QO3B:0-99; A:182-272COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD
1QOKA:27-146; A:162-260MFE-23 AN ANTI-CARCINOEMBRYONIC ANTIGEN SINGLE-CHAIN FV ANTIBODY
1URLA:1-118N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH GLYCOPEPTIDE
1UWXK:110-213; L:110-213; K:3-109; L:3-109; H:115-215; M:115-215; H:2-114; M:2-114P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
1UYWL:109-211; L:1-108; N:1-108; H:114-212; M:114-212; H:2-113; M:2-113; N:109-211CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
1UZ6E:108-210; L:108-210; M:108-210; V:108-210; P:114-213; W:114-213; H:114-213; F:114-213; E:1-107; L:1-107; M:1-107; V:1-107; F:1-112; H:1-112; P:1-112; W:1-112ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED
1UZ8A:108-210; B:114-213; H:114-213; A:1-107; L:1-107; B:1-112; H:1-112; L:108-210ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X
1WBXB:1-99; A:182-272CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1WBYB:1-99; A:182-272CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1WBZB:1-99; D:1-99; C:182-275; A:182-274CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1WC7A:109-214; L:109-210; A:1-108; L:1-108; B:114-214; H:114-212; B:1-113; H:1-113FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
1WCBA:109-214; L:109-214; A:1-108; L:1-108; B:114-214; H:114-213; B:1-113; H:1-113PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
2BMKA:109-214; L:109-214; A:1-108; L:1-108; B:114-214; H:114-214; B:1-113; H:1-113FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
2BOBB:109-211; B:1-108; A:119-217; A:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
2BOCB:109-211; B:1-108; A:119-217; A:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
2BRRL:109-211; X:2-108; L:1-108; H:114-215; Y:114-215; H:2-113; Y:1-113; X:109-211COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
2BVEA:1-119; B:1-119STRUCTURE OF THE N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH 2-PHENYL-PROP5AC
2C1PA:109-213; L:2-108; A:1-108; B:114-215; H:114-214; B:2-113; H:2-113; L:109-213FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE
2CIIB:1-99; A:182-272THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE
2CJUL:1-107; H:1-113CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5-OXAZOLONE NQ16-113.8 SCFV IN COMPLEX WITH PHOXGABA
2CLVB:1-99; A:182-274; H:182-274; P:1-99MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE
2CLZB:1-99; A:182-274; H:182-274; P:1-99MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE
2FATL:108-210; H:1-114; L:1-107; H:115-209AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
2JK5B:109-211; A:119-217; A:1-118POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
2R1WA:108-210; B:112-210; A:1-107; B:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R1XA:108-210; B:112-210; A:1-107; B:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R1YA:108-210; B:112-210; A:1-107; B:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R23A:108-210; B:112-210; A:1-107; B:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2BA:108-210; B:112-210; A:1-107; B:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2EA:108-210; B:112-210; A:1-107; B:1-111CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2HA:108-210; B:112-210; A:1-107; B:1-111STRUCTURE OF S25-2 IN COMPLEX WITH KO
2RGSA:338-442; B:338-443; A:238-337; B:238-337FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS
2UUDK:1-107; L:1-107; H:1-113; J:1-113CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5-OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN
2UYLA:115-214; M:115-214; V:115-214; X:115-214; A:1-113; M:1-113; V:1-113; X:1-113; B:120-218; N:120-218; W:120-218; Y:120-218; B:1-119; N:1-119; W:1-119; Y:1-119CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2V2TA:278-372; B:246-350X-RAY STRUCTURE OF A NF-KB P50-RELB-DNA COMPLEX
2V7HA:108-211; L:108-211; B:1-121; H:1-121; A:1-107; L:1-107; H:122-220; B:122-220CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI-MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
2VE6B:1-99; A:182-272; D:182-272; G:182-272; J:182-272; E:1-99; H:1-99; K:1-99CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
2VL5B:113-217; B:1-112; D:1-112; A:120-218; C:120-218; A:1-119; C:1-119; D:113-216STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2VOL  [entry was replaced by entry 3ZO0 without any CATH domain information]
2VQ1A:109-212; E:109-212; B:114-213; F:114-213; B:1-113; F:1-113ANTI TRIMERIC LEWIS X FAB54-5C10-A
2VXTL:109-211; H:114-212; H:1-113CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
2VXUL:109-211; M:109-211; H:114-212; I:114-212; H:1-113; I:1-113CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT
2W0FB:109-211; A:119-217; A:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
2W60B:114-217; A:119-215; A:1-118ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4
2W65B:114-217; D:114-217; A:119-215; C:119-215; A:1-118; C:1-118ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
2Z91B:109-211; D:109-211; B:1-108; D:1-108; A:114-212; C:114-212; A:3-113; C:3-113CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
2Z92B:109-211; B:1-108; A:114-212; A:3-113CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
2Z93D:109-205; D:1-108; C:114-213; C:3-113CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C-ABCD
2ZOKB:1-99; D:1-99; F:1-99; H:1-99; C:182-275; G:182-274; E:182-276; A:182-276CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
2ZOLB:2-99; A:182-274; C:182-274; D:2-99CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510
2ZPKI:114-210; H:114-210; L:2-108; M:2-109; H:2-113; I:2-113; L:109-210; M:110-208CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
2ZSVB:1-99; A:182-274; C:182-274; D:1-99CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598
2ZSWB:2-99; A:182-274; C:182-274; E:182-274; G:182-274; D:2-99; F:2-99; H:2-99CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
3BP5A:1-114CRYSTAL STRUCTURE OF THE MOUSE PD-1 AND PD-L2 COMPLEX
3BP6A:1-112CRYSTAL STRUCTURE OF THE MOUSE PD-1 MUTANT AND PD-L2 COMPLEX
3BPCA:108-210; B:112-210; A:1-107; B:1-111CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4-EPI-2,3-DEHYDRO KDO (4.8) KDO
3BYTA:2-110; C:2-117; E:2-117; G:2-117A COMPLEX BETWEEN A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN C3 AND THE VARIABLE DOMAIN OF THE MURINE T CELL RECEPTOR BETA CHAIN 8.2
3BYYA:2-117MANIPULATING THE COUPLED FOLDING AND BINDING PROCESS DRIVES AFFINITY MATURATION IN A PROTEIN-PROTEIN COMPLEX
3BZ4C:109-213; B:114-215; D:114-215; F:114-215; H:114-215; A:1-108; C:1-108; E:1-108; G:1-108; B:1-113; D:1-113; F:1-113; H:1-113; A:109-211; E:109-211; G:109-211CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
3C5SA:109-213; B:114-215; D:114-215; A:1-108; C:1-108; B:1-113; D:1-113; C:109-212CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
3C6SC:109-213; B:114-215; D:114-215; F:114-215; H:114-215; A:1-108; C:1-108; E:1-108; G:1-108; B:1-113; D:1-113; F:1-113; H:1-113; A:109-211; E:109-211; G:109-211CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
3CC5B:1-99; E:1-99; A:182-272; D:182-272H-2DB COMPLEX WITH HUMAN GP100
3CCHB:1-99; A:182-272; D:182-272; G:182-272; J:182-272; E:1-99; H:1-99; K:1-99H-2DB COMPLEX WITH MURINE GP100
3CH1B:1-99; E:1-99; H:1-99; A:182-272; D:182-272; K:1-99; G:182-272; J:182-272CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
3CPLB:1-99; A:182-272; C:182-272; D:1-99CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH A VARIANT M6A OF THE NP366 PEPTIDE FROM INFLUENZA A VIRUS
3CUPA:82-181; B:94-188CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE I-AG7 IN COMPLEX WITH THE PEPTIDE GAD221-235
3CVHB:1-99; L:108-209; R:108-209; L:1-107; R:1-107; A:182-272; M:182-272; H:121-219; Q:121-219; N:1-99; H:1-120; Q:1-120HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3CVIL:108-209; L:1-107; H:121-219; H:1-120HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3CXDL:109-211; L:1-108; H:117-214; H:1-116CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE
3D69B:114-214; H:114-214; B:1-113; H:1-113CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12
3DO7A:279-383; B:225-322X-RAY STRUCTURE OF A NF-KB P52/RELB/DNA COMPLEX
3DSFL:109-211; L:1-108; H:117-214; H:1-116CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE
3DURA:1-106; C:1-106; B:1-111; D:1-111CRYSTAL STRUCTURE OF SAG173-04
3DUSA:1-106; C:1-106; B:1-113; D:1-113CRYSTAL STRUCTURE OF SAG506-01, ORTHORHOMBIC, TWINNED, CRYSTAL 1
3DUUA:1-106; C:1-106; B:1-113; D:1-113CRYSTAL STRUCTURE OF SAG506-01, ORTHORHOMBIC, TWINNED, CRYSTAL 2
3DV4A:1-106; B:1-113CRYSTAL STRUCTURE OF SAG506-01, TETRAGONAL, CRYSTAL 1
3DV6A:1-106; B:1-113CRYSTAL STRUCTURE OF SAG506-01, TETRAGONAL, CRYSTAL 2
3E2HC:2-118; B:2-115STRUCTURE OF THE M67 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3E3QE:1-118; F:1-118; J:1-118; N:1-118; S:1-118; W:1-118; a:1-118; e:1-118; C:2-115; D:2-115; I:2-115; M:2-115; R:2-115; V:2-115; Z:2-115; d:2-115STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3E6FB:1-99; A:182-272MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PA9, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
3E6HB:1-99; A:182-272MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PI10, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
3ECBB:1-99; A:182-272CRYSTAL STRUCTURE OF MOUSE H-2DD IN COMPLEX WITH PEPTIDE P18-I10 DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120
3EOTL:110-214; H:119-216; H:1-118CRYSTAL STRUCTURE OF LAC031, AN ENGINEERED ANTI-VLA1 FAB
3ESUF:1004-1103CRYSTAL STRUCTURE OF ANTHRAX-NEUTRALIZING SINGLE-CHAIN ANTIBODY 14B7
3ESVF:1004-1103; G:1004-1103CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18
3ET9F:1004-1103CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY 1H
3ETBF:1004-1103; G:1004-1103; H:1004-1103; I:1004-1103CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18 COMPLEXED WITH ANTHRAX PROTECTIVE ANTIGEN DOMAIN 4
3EYSH:124-222; H:1-123PFA1 FAB FRAGMENT COMPLEXED WITH PYRO-GLU3-A-BETA (3-8)
3EYUH:124-226; H:1-123PFA1 FAB FRAGMENT COMPLEXED WITH ROR2(518-525)
3FFDA:119-217; A:1-118STRUCTURE OF PARATHYROID HORMONE-RELATED PROTEIN COMPLEXED TO A NEUTRALIZING MONOCLONAL ANTIBODY
3FO9A:109-214; B:114-227; H:114-227; B:1-113; H:1-113; L:109-214CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB' IN COMPLEX WITH HAPTEN 1,3-DIKETONE
3FOLB:0-99; A:182-272CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFERI
3FOMB:0-99; A:182-272CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE IQQSIERL
3FONB:0-99; D:0-99; A:182-272; C:182-272CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI
3FTGB:0-99; A:182-272CRYSTAL STRUCTURE OF H2DB IN COMPLEX WITH NP366-N3A VARIANT PEPTIDE FROM INFLUENZA
3G08B:2-98; A:185-279CRYSTAL STRUCTURE OF THE ALPHA-GALACTOSYLCERAMIDE ANALOG OCH IN COMPLEX WITH MOUSE CD1D
3G5VA:108-211; B:117-213; B:1-116ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3G5XA:108-211; C:108-211; B:115-213; D:115-213; B:1-114; D:1-114ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3G5YA:108-211; B:117-215; B:1-116ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3G5ZA:108-211; B:117-215; B:1-116ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3GGWA:109-213; D:114-215; B:114-214; B:1-113; D:1-113; C:109-214CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A CARBOHYDRATE-MIMETIC PEPTIDE
3GK8L:109-211; H:1-120; H:121-220X-RAY CRYSTAL STRUCTURE OF THE FAB FROM MAB 14, MOUSE ANTIBODY AGAINST CANINE PARVOVIRUS
3GKZA:9-138CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN COMPLEX METHAMPHETAMINE
3GM0A:9-138ANTI-METHAMPHETAMINE SINGLE CHAIN FV IN COMPLEX WITH MDMA
3GMLB:1-99; A:185-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH
3GMMB:1-99; A:185-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH
3GMNB:1-99; A:185-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH
3GMOB:1-99; A:185-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF
3GMPB:1-99; A:185-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25
3GMQB:1-99; A:185-281STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED
3GMRB:1-99; A:185-279STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH, DIFFERENT SPACE GROUP
3GNMH:1-118; H:119-218THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
3HE6B:1-99; C:1-116; A:185-280CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
3HE7B:2-99; C:1-116; A:185-280CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
3HKFA:341-445; A:241-340MURINE UNGLYCOSYLATED IGG FC FRAGMENT
3HNSL:108-211; H:1-118; H:119-220CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
3HNTL:108-211; H:1-118; H:119-220CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
3HNVL:108-211; H:1-118; H:119-220CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)
3HZKA:108-210; B:114-211; B:1-113CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
3HZMA:108-210; B:114-211; B:1-113CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
3HZVA:108-210; B:114-211; B:1-113CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
3HZYA:108-210; B:114-211; B:1-113CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3I02A:108-213; C:108-207; B:114-212; D:114-212; B:1-113; D:1-113CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3I2CL:112-215; H:121-218; H:1-120CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088
3IFLH:1-120X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12A11) COMPLEX
3IFNH:1-120X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-40:12A11) COMPLEX
3IFOA:1-123; H:1-123X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
3IFPA:2-123; C:2-123; E:2-123; H:2-123X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
3IGAB:109-211; A:119-217; A:1-118POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
3IJHA:108-210; C:108-210; B:114-213; D:114-213; B:1-113; D:1-113STRUCTURE OF S67-27 IN COMPLEX WITH KO
3IJSA:108-210; C:108-210; B:114-213; D:114-213; B:1-113; D:1-113STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
3IJYC:108-210; A:108-210; B:114-213; D:114-213; B:1-113; D:1-113STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3IKCA:108-210; C:108-210; B:114-213; D:114-213; B:1-113; D:1-113STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3ILPB:1-99; A:185-279STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2F FROM BORRELIA BURGDORFERI
3ILQD:2-99; C:185-279STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2C FROM BORRELIA BURGDORFERI
3IXTL:109-212; B:109-211; H:114-212; A:114-212; A:1-113; H:1-113CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
3JXAA:120-221; B:120-221; B:22-119; A:22-119; A:222-313; B:222-313IMMUNOGLOBULIN DOMAINS 1-4 OF MOUSE CNTN4
3KLDA:120-221; A:23-119; A:222-313PTPRG CNTN4 COMPLEX
3KS0H:118-213; K:118-213; H:1-117; K:1-117CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4
3L1OL:109-211; H:124-227; H:1-123CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE, CRYSTALLIZED IN THE PRESENCE OF ZINC
3L3HB:1-99; A:182-272X-RAY CRYSTAL STRUCTURE OF THE F6A MUTANT OF INFLUENZA A ACID POLYMERASE EPITOPE PA224 BOUND TO MURINE H2-DB MHC